Risk Materials

Educational Risk Minimisation Materials to help reduce the risk associated with using this medicine.

Benepali ® (etanercept): Brief training on additional Risk Minimisation Measures_v9.0_22Jan16 (UK/IE)

Developed to educate healthcare professionals that benepali is not for paediatric use and to prevent or reduce medication errors for pre-filled pen and pre-filled syringe.

For Healthcare Professionals

Benepali Patient Alert Card

The PAC is located inside the Benepali box and should be carried by patients during treatment and for 2 months after the last dose. The PAC contains the following key elements for patients treated with Benepali: • The risk of opportunistic infections and tuberculosis (TB) • The risk of Congestive Heart Failure (CHF). • Benepali is not for use in children

Benepali Quick Reference Guide for Pre-filled Pen (PFPen EN v1.1)

Developed as a teaching guide for healthcare professionals to facilitate training of the patients in the safe use of the pre-filled pen.

For Healthcare Professionals

Send us feedback

If you would like to make a comment or send us feedback on this material, click here.